<DOC>
	<DOCNO>NCT02426905</DOCNO>
	<brief_summary>A study review Wilson disease patient previously prescribe d- Penicillamine change trientine treatment disease , follow 12 month .</brief_summary>
	<brief_title>Study Assess Long-Term Outcomes Trientine Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine</brief_title>
	<detailed_description>A retrospective study review Wilson disease patient previously prescribe d- Penicillamine change trientine treatment disease , follow prospectively 12 month .</detailed_description>
	<mesh_term>Hepatolenticular Degeneration</mesh_term>
	<mesh_term>Penicillamine</mesh_term>
	<mesh_term>Trientine</mesh_term>
	<criteria>Patients age 1 year 90 year age . Physician establish diagnosis Wilson disease base Ferenci score &gt; 3 . Documented treatment dPenicillamine , withdrawal treatment Penicillamine , follow treatment trientine least 6 month date inform consent . Able/willing provide write informed consent . For enrolment prospective part , enrolment retrospective part study require . Incomplete history medication use trientine initial diagnosis late follow . Unavailable outcome data hepatic neurological course disease assessment time point . Patients acute liver failure fulminant hepatic disease fatal outcome . Hypersensitivity trientine severe anaemia .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>